论文部分内容阅读
应用~(125)I-lipiodol抗癌乳剂经肝动脉灌注治疗不可切除的中晚期肝癌44例,取得显著的疗效,所有病例均有不同程度的症状改善,其中30例AFP阳性患者、25例术后一月完全转阴,5例AFP值下降至200ng/ml以下;术前AFP值增高(100～400ng/ml)4例患者,术后均转为阴性,20例肝区疼痛消失;18例肿瘤缩小。本法的主要特点,即将肿瘤区域的局部放疗、化疗和栓塞疗法三者结合在一起,不同环节的联合作用,起到综合抗癌的效果,为肝癌的导向治疗开辟了新的方法。
The use of ~(125)I-lipiodol anticancer emulsion for hepatic arterial infusion for the treatment of 44 cases of unresectable advanced hepatocellular carcinoma, achieved remarkable curative effect, all cases have different degrees of symptom improvement, 30 cases of AFP positive patients, 25 cases of surgery In the following month, it completely turned negative, and the AFP value in 5 cases dropped below 200ng/ml; the preoperative AFP value increased (100-400ng/ml) in 4 patients and all patients turned negative after surgery. 20 cases of liver pain disappeared; 18 cases The tumor shrinks. The main features of this method are the combination of local radiation therapy, chemotherapy and embolization therapy in the tumor area. The combined effects of different aspects play a comprehensive anti-cancer effect, opening up new methods for the treatment of liver cancer.